Dice CEO: Energy, T...
Health Care: Drugs
Alexion Pharmaceuticals Inc. (ALXN: NASDAQ)
$87.60 -2.97 | -3.28%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 87.60 | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 0.55 | 0.58 | 0.98 |
| Price to Sales (TTM) | 19.01 | 4.62 | 1.42 |
| Price to Book (MRQ) | 13.51 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 60.26 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | 77.00 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | -51.10 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 47.30 | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 44.80 | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 113.70 | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | 69.30 | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | 69.30 | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 6.42 | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 1.80 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 2.30 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.20 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.29 | 0.45 | 0.96 |
| Interest Coverage (TTM) | 90.20 | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 90.30 | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | 91.20 | 83.50 | 47.70 |
| EBITD Margin (TTM) | 34.40 | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | -1.07 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 29.80 | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 19.80 | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.22 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 24.90 | 5.30 | 7.00 |
| Return on Assets (TTM) | 9.60 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | 12.70 | 2.20 | 2.50 |
| Return on Investment (TTM) | 13.30 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | 15.00 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 855,196.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | 192,359.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | 3.70 | 5.80 | 7.60 |
| Inventory Turnover (TTM) | 1.00 | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.50 | 0.40 | 0.40 |
Portfolios with ALXN
- Portfolio NameUser Type
- UserLong Term Stock Picks by Co...
- UserGFNN Stockdiagnostics 17
- ContributorBreakout Stocks Of The Week...
- UserWatchlist-CTS
- UserFreewilly's Stockpicker Blo...
- UserFinancial Machine.
- UserHealth
- UserGFNN Stockdiagnostics 11
- UserRookie
- UserGFNN Stockdiagnostics 4
Latest ALXN Headlines from TheStreet
- 5 Stocks Poised for Breakouts 05.25.12 | 11:05 am
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Health Care Winner 05.22.12 | 05:05 pm
- 3 Stocks I Saw on TV, May 17
05.17.12 | 07:05 am - Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Winner 05.15.12 | 05:05 pm
- Alexion Pharmaceuticals Management Presents At Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript) 05.11.12 | 06:05 pm
- Vertex Is the Next Gilead Sciences or Alexion 05.07.12 | 11:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Health Care Winner 05.01.12 | 05:05 pm
- Alexion's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.24.12 | 04:04 pm
- The Week Ahead: Housing Data, GDP and Earnings 04.22.12 | 06:04 pm
Press Releases for ALXN
- Alexion To Present At Investor Conferences - Business Wire 05.29.12 | 10:05 am
- Alexion To Present At Deutsche Bank Securities 37th Annual Health Care Conference - Business Wire 04.30.12 | 10:04 am
- Alexion Reports First Quarter 2012 Results - Business Wire 04.24.12 | 06:04 am
- Alexion Pharmaceuticals To Report First Quarter 2012 Results On Tuesday, April 24, 2012 - Business Wire 04.10.12 | 10:04 am
- Asfotase Alfa Significantly Decreased TNSALP Substrates And Improved 6-Minute Walk Test Results In Adolescents And Adults With Hypophosphatasia (HPP) - Business Wire 03.29.12 | 11:03 am
- New England Journal Of Medicine Publishes Data From Phase 2 Study Of Asfotase Alfa In Life-Threatening Hypophosphatasia - Business Wire 03.07.12 | 05:03 pm
- Alexion To Present At Barclays Capital Global Healthcare Conference - Business Wire 03.06.12 | 10:03 am
- Alexion Joins EURORDIS, NORD And Patient Organizations Worldwide In Celebrating Rare Disease Day 2012 - Business Wire 02.29.12 | 06:02 am
- Alexion To Present At The Cowen And Company 32nd Annual Health Care Conference - Business Wire 02.27.12 | 10:02 am
- Alexion To Present At The Leerink Swann 2012 Global Healthcare Conference - Business Wire 02.10.12 | 10:02 am
Partner Headlines for ALXN
- Some Leaders Building Bases As Market Corrects - Investor's Business Daily 05.31.12 | 06:05 pm
- Leaders Stage Comeback; Some Form Bases - Investor's Business Daily 05.25.12 | 06:05 pm
- After Hours Most Active for May 24, 2012 : EP, KMI, ALXN, S, XRX, GLW, WMB, QQQ, ORCL, FB, TEVA, TIBX - NASDAQ 05.24.12 | 08:05 pm
- Stock Market Gains Fade After Higher Open - Investor's Business Daily 05.24.12 | 10:05 am
- Some Quality Stocks Are Working On Potential Bases - Investor's Business Daily 05.23.12 | 02:05 pm
- Stocks Gain, But Facebook Does Another Face Plant - Investor's Business Daily 05.22.12 | 03:05 pm
- Stocks Advance In Mixed Volume; Retailer DSW Hits New High - Investor's Business Daily 05.22.12 | 01:05 pm
- Stocks Gain In Mixed Turnover; Mellanox Breaks Out - Investor's Business Daily 05.22.12 | 12:05 pm
- Stock Futures Narrowly Higher; Best Buy Surges - Investor's Business Daily 05.22.12 | 09:05 am
- Stocks Surge As China Vows Growth Push - Investor's Business Daily 05.21.12 | 04:05 pm
